Protein Engineering, Vol. 12, No. 12, 1105-1111,
December 1999
© 1999 Oxford University Press
Inhibition of ßS-chain dependent polymerization by synergistic complementation of contact site perturbations of
-chain: application of semisynthetic chimeric
-chains
1 Division of Hematology, Department of Medicine and 2 Department of Physiology and Biophysics, Albert Einstein College of Medicine, 1300, Morris Park Avenue, Bronx, NY 10461 and 3 Structural Bioinformatics, San Diego, CA 92127, USA
Mouse
130-horse
31141 chimeric
-chain, a semisynthetic super-inhibitory
-chain, inhibits ßS-chain dependent polymerization better than both parent
-chains. Although contact site sequence differences are absent in the
130 region of the chimeric chain, the four sequence differences of the region
17-22 could induce perturbations of the side chains at
16,
20 and
23, the three contact sites of the region. A synergistic complementation of such contact site perturbation with that of horse
31141 probably results in the super-inhibitory activity of the chimeric
-chain. The inhibitory contact site sequence differences, by themselves, could also exhibit similar synergistic complementation. Accordingly, the polymerization inhibitory activity of Hb Le-Lamentin (LM) mutation [His20(
)
Gln], a contact site sequence difference, engineered into humanhorse chimeric
-chain has been investigated to map such a synergistic complementation. Gln20(
) has little effect on the O2 affinity of HbS, but in humanhorse chimeric
-chain it reduces the O2 affinity slightly. In the chimeric
-chain, Gln20(
) increased sensitivity of the ßß cleft for the DPG influence, reflecting a cross-talk between the
1ß1 interface and ßß cleft in this semisynthetic chimeric HbS. In the human
-chain frame, the polymerization inhibitory activity of Gln20(
) is higher compared with horse
130, but lower than mouse
130. Gln20(
) synergistically complements the inhibitory propensity of horse
31141. However, the inhibitory activity of LMhorse chimeric
-chain is still lower than that of mousehorse chimeric
-chain. Therefore, perturbation of multiple contact sites in the
130 region of the mousehorse chimeric
-chain and its linkage with the inhibitory propensity of horse
31141 has been now invoked to explain the super-inhibitory activity of the chimeric
-chain. The `linkage-map' of contact sites can serve as a blueprint for designing synergistic complementation of multiple contact sites into
-chains as a strategy for generating super-inhibitory antisickling hemoglobins for gene therapy of sickle cell disease.
Keywords: chimeric HbS/HbS polymerization/intermolecular contact sites/linkage map/protein engineering/super-inhibitory
-chain